David M. Konys
Plus aucun poste en cours
Profil
Mr. David M.
Konys is Vice President-Manufacturing Operations at Alnylam Pharmaceuticals, Inc.
Mr. Konys was previously employed as President & Managing Director by Biogen Idec Canada, Inc. and Vice President-Corporate Development by Ingenium Pharmaceuticals GmbH.
Anciens postes connus de David M. Konys
| Sociétés | Poste | Fin |
|---|---|---|
| Biogen Canada, Inc. | President | - |
Ingenium Pharmaceuticals GmbH
 Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Biogen Canada, Inc. | |
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Commercial Services |